| KOMISJA NADZORU FINANSOWEGO | |||||||||||
| Raport bieżący nr | 2 | / | 2016 | ||||||||
| Data sporządzenia: | 2016-01-12 | ||||||||||
| Skrócona nazwa emitenta | |||||||||||
| MILESTONE MEDICAL | |||||||||||
| Temat | |||||||||||
| Information on a transaction concluded by a member of the Board of Directors | |||||||||||
| Podstawa prawna | |||||||||||
| Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osób mających dostęp do informacji poufnych | |||||||||||
| Treść raportu: | |||||||||||
| Pursuant to Article 160 section 4 of the Financial Instruments Trading Act, the Board of Directors of Milestone Medical Inc. (the “Company") informs that on January 11, 2016, the Company received a notification from Mr. Leonard Osser, a Member of the Board of Directors regarding his acquisition of Company’s shares. Mr. Leonard Osser is obliged to notify of the transaction due to the fact that he holds the position of Chief Executive Officer and Director of the Company, pursuant to art. 160 section 1.1 of the Financial Instruments Trading Act. Mr. Leonard Osser on January 5, 2016 acquired 250,000 common bearer’s shares of the Company. The transaction took place outside New Connect Market (organized trading). The transaction was executed in New York. Mr. Leonard Osser acquired the aforesaid 250,000 common bearer’s shares for the average price of USD 0.45 for one share, i.e. for the total price of USD 112,500. Legal basis: Art. 160 sec. 4 of the Financial Instruments Trading Act – information on transactions effected by individuals having access to inside information | |||||||||||
| Załączniki | |||||||||||
| Plik | Opis | ||||||||||
| L.Osser art_160 notification 05012016.pdf | L.Osser art.160 notification | ||||||||||
| MESSAGE (ENGLISH VERSION) | |||
| MILESTONE MEDICAL INC | |||||||||||||
| (pełna nazwa emitenta) | |||||||||||||
| MILESTONE MEDICAL | |||||||||||||
| (skrócona nazwa emitenta) | (sektor wg. klasyfikacji GPW w W-wie) | ||||||||||||
| NJ 07039 | . | ||||||||||||
| (kod pocztowy) | (miejscowość) | ||||||||||||
| South Orange Avenue Livingston | 220 | ||||||||||||
| (ulica) | (numer) | ||||||||||||
| +11 973 535 2717 | +11 973 535 2829 | ||||||||||||
| (telefon) | (fax) | ||||||||||||
| (e-mail) | (www) | ||||||||||||
| 27-5484393 | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2016-01-12 | Joseph D'Agostino | Chief Financial Officer | Joseph D'Agostino | ||
